• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 231/14 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 231/14

Total number of patents in this class: 1171

10-year publication summary

71
93
79
71
76
79
66
54
47
21
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bayer Cropscience AG
1885
60
Theravance Biopharma R&D IP, LLC
425
48
Syngenta Participations AG
1581
38
BASF SE
21150
36
BioCryst Pharmaceuticals, Inc.
179
31
Syngenta Crop Protection AG
6513
28
Orion Corporation
750
19
Takeda Pharmaceutical Company Limited
2718
18
Sumitomo Chemical Company, Limited
9055
15
Activesite Pharmaceuticals, Inc.
18
15
Syngenta Limited
436
14
AstraZeneca AB
2832
12
Solvay SA
958
12
Dow AgroSciences LLC
1196
11
sanofi-aventis
327
11
F. Hoffmann-La Roche AG
7837
10
Hoffmann-La Roche Inc.
3699
10
Bayer Intellectual Property GmbH
2405
10
Loxo Oncology, Inc.
82
10
Research Triangle Institute
415
10
Other owners 753